<mets:mets OBJID="eprint_5859" LABEL="Eprints Item" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mets:metsHdr CREATEDATE="2026-07-05T13:48:55Z"><mets:agent ROLE="CUSTODIAN" TYPE="ORGANIZATION"><mets:name>Repositori BKPK</mets:name></mets:agent></mets:metsHdr><mets:dmdSec ID="DMD_eprint_5859_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:titleInfo><mods:title>EVALUASI PENGGUNAAN ARTESUNAT-AMODIAKUIN (Artesdiakuin)&#13;
PADA PENGOBATAN MALARIA TANPA KOMPLIKASI DI PUSKESMAS&#13;
PENYANDINGAN DAN TANJUNG LENGKAYAP KABUPATEN OKU</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Santoso</mods:namePart><mods:namePart type="family">Santoso</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Malaria is still a public health problem in Ogan Komering Ulu (OKU) Regency. The treatment of malaria for Plasmodium falciparum in the OKU regency has been using artesdiaquine since 2007 and for Plasmodium vivax in 2009. The purpose of this study was to assess the effectiveness Artesdiaquine as anti-malarial drugs and the side effects of therapeutic. This research was conducted using an observational surveys, in P falciparum and P. vivax patient, by examination and observation of subjects during 28 days, in 0 day (DO), first day (Dl), 2nd (D2), 3th (D3), 7th (D7), 14th (DI4), 21th (D21) and 28th day (D28). Theraphy of Artesdiaquine on DO, Dl and D2 (10 mg/kg amodiaquine and 4 mg/kg artesunate), while primaquine on DO (0.75 mg/kg) for P falciparum patient and DO-DI4 (0.25 mg/kg) for P.vivax patient. The side effects observed on DO, Dl , D2 and D3, while the assessment of drug efficacy after D28. The results showed that efficacy of Artesdiaquine-antimalarial drugs combinations for P.vivax patients has good (100%), but in P falciparum patients only 87% with criteria of Adequate Clinical and Parasitological Response (A CPR). Plasmodium falciparum patient with early treatment failure (ETF) were found in 3 people (13%). The side effects of artesdiaquine were dizziness, nausea, vomiting and stomach. Patients P falciparum who did not experience medication side effects as many as 5 of 23 patients (21.7%). While in P.vivax patients were 2 of 12 patients (16.7%). Clinical symptom in P. vivax patients higher than P falciparum patients. Artesdiaquine more effective to treatment P. vivax than P falciparum patients. Side effect of treatment anti malarial higher in P falciparum than P. vivax patients.</mods:abstract><mods:classification authority="lcc">WC Communicable Diseases</mods:classification><mods:originInfo><mods:dateIssued encoding="iso8601">2011</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Badan Penelitian dan Pengembangan Kesehatan</mods:publisher></mods:originInfo><mods:genre>Article</mods:genre></mets:xmlData></mets:mdWrap></mets:dmdSec><mets:amdSec ID="TMD_eprint_5859"><mets:rightsMD ID="rights_eprint_5859_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:useAndReproduction>
<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by its own author:</strong>
In self-archiving this collection of files and associated bibliographic
metadata, I grant Repositori BKPK the right to store
them and to make them permanently available publicly for free on-line.
I declare that this material is my own intellectual property and I
understand that Repositori BKPK does not assume any
responsibility if there is any breach of copyright in distributing these
files or metadata. (All authors are urged to prominently assert their
copyright on the title page of their work.)</p>

<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by someone other than its
author:</strong> I hereby declare that the collection of files and
associated bibliographic metadata that I am archiving at
Repositori BKPK is in the public domain. If this is
not the case, I accept full responsibility for any breach of copyright
that distributing these files or metadata may entail.</p>

<p xmlns="http://www.w3.org/1999/xhtml">Clicking on the <em>Deposit Item Now</em> button indicates your agreement to these
terms.</p>
    </mods:useAndReproduction></mets:xmlData></mets:mdWrap></mets:rightsMD></mets:amdSec><mets:fileSec><mets:fileGrp USE="reference"><mets:file ID="eprint_5859_16403_1" SIZE="161726" OWNERID="http://www.badankebijakan.kemkes.go.id/repositori/id/eprint/5859/1/07490348-ad1b-4679-aac3-1a6974181f1f%20hal%2099-109.pdf" MIMETYPE="application/pdf"><mets:FLocat LOCTYPE="URL" xlink:type="simple" xlink:href="http://www.badankebijakan.kemkes.go.id/repositori/id/eprint/5859/1/07490348-ad1b-4679-aac3-1a6974181f1f%20hal%2099-109.pdf"></mets:FLocat></mets:file></mets:fileGrp></mets:fileSec><mets:structMap><mets:div DMDID="DMD_eprint_5859_mods" ADMID="TMD_eprint_5859"><mets:fptr FILEID="eprint_5859_document_16403_1"></mets:fptr></mets:div></mets:structMap></mets:mets>